Literature DB >> 32870977

Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies.

Rebecca Kahn, Lee Kennedy-Shaffer, Yonatan H Grad, James M Robins, Marc Lipsitch.   

Abstract

The extent and duration of immunity following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical outstanding questions about the epidemiology of this novel virus, and studies are needed to evaluate the effects of serostatus on reinfection. Understanding the potential sources of bias and methods for alleviating biases in these studies is important for informing their design and analysis. Confounding by individual-level risk factors in observational studies like these is relatively well appreciated. Here, we show how geographic structure and the underlying, natural dynamics of epidemics can also induce noncausal associations. We take the approach of simulating serological studies in the context of an uncontrolled or controlled epidemic, under different assumptions about whether prior infection does or does not protect an individual against subsequent infection, and using various designs and analytical approaches to analyze the simulated data. We find that in studies assessing whether seropositivity confers protection against future infection, comparing seropositive persons with seronegative persons with similar time-dependent patterns of exposure to infection by stratifying or matching on geographic location and time of enrollment is essential in order to prevent bias.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  SARS-CoV-2; bias (epidemiology); coronavirus disease 2019; epidemic dynamics; epidemics; immunity; seroprotection

Mesh:

Year:  2021        PMID: 32870977      PMCID: PMC7499481          DOI: 10.1093/aje/kwaa188

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Bias due to misclassification in the estimation of relative risk.

Authors:  K T Copeland; H Checkoway; A J McMichael; R H Holbrook
Journal:  Am J Epidemiol       Date:  1977-05       Impact factor: 4.897

2.  Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness.

Authors:  G Thomas Ray; Ned Lewis; Nicola P Klein; Matthew F Daley; Marc Lipsitch; Bruce Fireman
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

3.  Competing Effects of Indirect Protection and Clustering on the Power of Cluster-Randomized Controlled Vaccine Trials.

Authors:  Matt D T Hitchings; Marc Lipsitch; Rui Wang; Steven E Bellan
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

4.  Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.

Authors:  Juliet E Bryant; Andrew S Azman; Matthew J Ferrari; Benjamin F Arnold; Maciej F Boni; Yap Boum; Kyla Hayford; Francisco J Luquero; Michael J Mina; Isabel Rodriguez-Barraquer; Joseph T Wu; Djibril Wade; Guy Vernet; Daniel T Leung
Journal:  Sci Immunol       Date:  2020-05-19

5.  The ecological effects of individual exposures and nonlinear disease dynamics in populations.

Authors:  J S Koopman; I M Longini
Journal:  Am J Public Health       Date:  1994-05       Impact factor: 9.308

6.  The time course of the immune response to experimental coronavirus infection of man.

Authors:  K A Callow; H F Parry; M Sergeant; D A Tyrrell
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

7.  Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.

Authors:  Rebecca Kahn; Matt Hitchings; Steven Bellan; Marc Lipsitch
Journal:  Clin Trials       Date:  2018-01-27       Impact factor: 2.486

8.  Simulations for designing and interpreting intervention trials in infectious diseases.

Authors:  M Elizabeth Halloran; Kari Auranen; Sarah Baird; Nicole E Basta; Steven E Bellan; Ron Brookmeyer; Ben S Cooper; Victor DeGruttola; James P Hughes; Justin Lessler; Eric T Lofgren; Ira M Longini; Jukka-Pekka Onnela; Berk Özler; George R Seage; Thomas A Smith; Alessandro Vespignani; Emilia Vynnycky; Marc Lipsitch
Journal:  BMC Med       Date:  2017-12-29       Impact factor: 8.775

9.  Use of serological surveys to generate key insights into the changing global landscape of infectious disease.

Authors:  C Jessica E Metcalf; Jeremy Farrar; Felicity T Cutts; Nicole E Basta; Andrea L Graham; Justin Lessler; Neil M Ferguson; Donald S Burke; Bryan T Grenfell
Journal:  Lancet       Date:  2016-04-05       Impact factor: 79.321

10.  Network theory and SARS: predicting outbreak diversity.

Authors:  Lauren Ancel Meyers; Babak Pourbohloul; M E J Newman; Danuta M Skowronski; Robert C Brunham
Journal:  J Theor Biol       Date:  2005-01-07       Impact factor: 2.691

View more
  4 in total

1.  Cabbage and COVID-19.

Authors:  Joan B Soriano; Julio Ancochea
Journal:  Allergy       Date:  2021-03       Impact factor: 13.146

Review 2.  How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.

Authors:  Emma K Accorsi; Xueting Qiu; Eva Rumpler; Lee Kennedy-Shaffer; Rebecca Kahn; Keya Joshi; Edward Goldstein; Mats J Stensrud; Rene Niehus; Muge Cevik; Marc Lipsitch
Journal:  Eur J Epidemiol       Date:  2021-02-25       Impact factor: 8.082

3.  Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics.

Authors:  Kevin C Ma; Tigist F Menkir; Stephen Kissler; Yonatan H Grad; Marc Lipsitch
Journal:  Elife       Date:  2021-05-18       Impact factor: 8.140

4.  Comparative Evaluation of Rapid Isothermal Amplification and Antigen Assays for Screening Testing of SARS-CoV-2.

Authors:  Nol Salcedo; Brena F Sena; Xiying Qu; Bobby Brooke Herrera
Journal:  Viruses       Date:  2022-02-25       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.